AWHL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AWHL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Aspira Womens Health's Average Total Inventories for the three months ended in Dec. 2024 was $0.31 Mil. Aspira Womens Health's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.86 Mil. Hence, Aspira Womens Health's Days Inventory for the three months ended in Dec. 2024 was 32.68.
The historical rank and industry rank for Aspira Womens Health's Days Inventory or its related term are showing as below:
During the past 13 years, Aspira Womens Health's highest Days Inventory was 27.25. The lowest was 2.94. And the median was 12.20.
Aspira Womens Health's Days Inventory increased from Dec. 2023 (26.44) to Dec. 2024 (32.68). It might indicate that Aspira Womens Health's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year. Aspira Womens Health's Inventory Turnover for the three months ended in Dec. 2024 was 2.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aspira Womens Health's Inventory-to-Revenue for the three months ended in Dec. 2024 was 0.13.
The historical data trend for Aspira Womens Health's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspira Womens Health Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Days Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
2.94 | 9.93 | 23.16 | 25.46 | 27.25 |
Aspira Womens Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Days Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
26.44 | 22.50 | 21.04 | 26.10 | 32.68 |
For the Diagnostics & Research subindustry, Aspira Womens Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aspira Womens Health's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Aspira Womens Health's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as
Days Inventory (A: Dec. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2023 ) | + | Total Inventories (A: Dec. 2024 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2024 ) | * | Days in Period |
= | ( (0.227 | + | 0.326) | / | 2 ) | / | 3.703 | * | 365 |
= | 0.2765 | / | 3.703 | * | 365 | ||||
= | 27.25 |
Aspira Womens Health's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:
Days Inventory (Q: Dec. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2024 ) | + | Total Inventories (Q: Dec. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2024 ) | * | Days in Period |
= | ( (0.29 | + | 0.326) | / | 2 ) | / | 0.86 | * | 365 / 4 |
= | 0.308 | / | 0.86 | * | 365 / 4 | ||||
= | 32.68 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspira Womens Health (OTCPK:AWHL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aspira Womens Health's Inventory Turnover for the three months ended in Dec. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.86 | / | 0.308 | |
= | 2.79 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aspira Womens Health's Inventory to Revenue for the three months ended in Dec. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0.308 | / | 2.349 | |
= | 0.13 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Aspira Womens Health's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Nicole Sandford | director | 12117 BEE CAVES RD BLDG 3, STE 100, AUSTIN TX 78738 |
Minh Hoang Merchant | officer: General Counsel & Secretary | 1210 AVONDALE ROAD, HILLSBOROUGH CA 94010 |
Torsten Hombeck | officer: Chief Financial Officer | 529 W 42ND ST #6V, NEW YORK NY 10036 |
Celeste Rachelle Fralick | director | 2801 MESA ROAD, LUBBOCK TX 79403 |
Veronica Gh Jordan | director | C/O ALBANY MOLECULAR RESEARCH, INC., 26 CORPORATE CIRCLE, ALBANY NY 12212-5098 |
Stefanie L. Cavanaugh | director | 1120 S CAPITAL OF TX HWY, BLDG 1, STE 300, AUSTIN TX 78746 |
Ellen O'connor Vos | director | C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980 |
Jack W Schuler | 10 percent owner | 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045 |
Ryan Thinh Phan | officer: CSO & COO | 327 CARLTON AVE, LOS GATOS CA 95032 |
Jannie Prestridge Herchuk | director | 6331 LAVENDALE AVE, DALLAS TX 75230 |
Winfred Parnell | director | 6734 TALMADGE LANE, DALLAS TX 75230 |
Marlene Mclennan | officer: Interim Chief Financial Office | 400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401 |
Ruby Sharma | director | 24 ARNOLD DRIVE, PRINCETON JCT. NJ 08550 |
Robert D Auerbach | director | C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588 |
Valerie Barber Palmieri | director, officer: President and CEO | 63 INDIAN LEDGE RD., MONROE CT 06468 |
From GuruFocus
By Marketwired • 10-23-2024
By Marketwired • 12-03-2024
By GuruFocus News • 02-15-2025
By ACCESSWIRE • 04-17-2025
By ACCESSWIRE • 02-11-2025
By ACCESSWIRE • 01-10-2025
By Marketwired • 11-14-2024
By GuruFocus News • 11-15-2024
By ACCESSWIRE • 03-28-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.